Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aroldo Rizzo

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Autoimmunity Reviews|January 21, 2015
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the diseasePiero Ruscitti, Paola Cipriani, Paola Di Benedetto, et al.
Arthritis and Rheumatism|January 4, 2012
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitisFrancesco Ciccia, Antonina Accardo-Palumbo, Riccardo Alessandro, et al.
Rheumatology (Oxford, England)|March 8, 2014
Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndromeFrancesco Ciccia, Giuliana Guggino, Aroldo Rizzo, et al.
Rheumatology (Oxford, England)|August 1, 2012
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patientsFrancesco Ciccia, Aroldo Rizzo, Antonina Accardo-Palumbo, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammationFrancesco Ciccia, Antonina Accardo-Palumbo, Aroldo Rizzo, et al.
Clinical Transplantation|November 15, 2006
MTHFR C677T homozygous as risk factor for complications after OLT for cryptogenic cirrhosisLinda Pasta, Ciro Marrone, Mario D'Amico, et al.
Rheumatology (Oxford, England)|April 12, 2015
Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritisFrancesco Ciccia, Aroldo Rizzo, Giuliana Guggino, et al.
Annals of the Rheumatic Diseases|April 24, 2015
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitisFrancesco Ciccia, Giuliana Guggino, Aroldo Rizzo, et al.
Theranostics|June 10, 2016
MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for GliomaAlessia Lo Dico, Viviana Costa, Cristina Martelli, et al.
Rheumatology (Oxford, England)|March 7, 2014
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activityFrancesco Ciccia, Aroldo Rizzo, Riccardo Alessandro, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Autoimmunity Reviews|January 21, 2015
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the diseasePiero Ruscitti, Paola Cipriani, Paola Di Benedetto, et al.
Arthritis and Rheumatism|January 4, 2012
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitisFrancesco Ciccia, Antonina Accardo-Palumbo, Riccardo Alessandro, et al.
Rheumatology (Oxford, England)|March 8, 2014
Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndromeFrancesco Ciccia, Giuliana Guggino, Aroldo Rizzo, et al.
Rheumatology (Oxford, England)|August 1, 2012
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patientsFrancesco Ciccia, Aroldo Rizzo, Antonina Accardo-Palumbo, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammationFrancesco Ciccia, Antonina Accardo-Palumbo, Aroldo Rizzo, et al.
Clinical Transplantation|November 15, 2006
MTHFR C677T homozygous as risk factor for complications after OLT for cryptogenic cirrhosisLinda Pasta, Ciro Marrone, Mario D'Amico, et al.
Rheumatology (Oxford, England)|April 12, 2015
Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritisFrancesco Ciccia, Aroldo Rizzo, Giuliana Guggino, et al.
Annals of the Rheumatic Diseases|April 24, 2015
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitisFrancesco Ciccia, Giuliana Guggino, Aroldo Rizzo, et al.
Theranostics|June 10, 2016
MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for GliomaAlessia Lo Dico, Viviana Costa, Cristina Martelli, et al.
Rheumatology (Oxford, England)|March 7, 2014
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activityFrancesco Ciccia, Aroldo Rizzo, Riccardo Alessandro, et al.
Pageof 7